Figure 10.(A) The mutational landscape of two immune subtypes (high risk and low risk) (B) The potential sensitive targeted drugs in high risk group and low risk group.
Figure 10 — Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma | Aging
